Clinical Trial Update: Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD

View source ↗

Summary

Massachusetts General Hospital is conducting a trial to evaluate digital, accessible remote olfactory-based health assessments for preclinical Alzheimer's disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Behavioral Impairment
• Cognitive Impairment
• Subjective Cognitive Decline

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Subjective Cognitive Concerns, Mild Cognitive Impairment | Status: RECRUITING